Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-08-18

Clinical Trial Update: Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating neuro-electrostimulation to treat salivary gland hypofunction in xerostomia and Sjögren's syndrome; status not disclosed in the snipp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuro-electrostimulation therapy device (neuro-electrostimulation therapy device)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Xerostomia, Polypharmacy | Phase 2, Phase 3 | Status: UNKNOWN